use of rectal tube in vaginal cuff HDR-brachytherapy: an unexpected advantage

被引:0
|
作者
Cerrotta, A. [1 ]
Tenconi, C. [2 ]
Pappalardi, B. [1 ]
Giandini, T. [2 ]
Naimo, S. [1 ]
Mazzeo, D. [2 ]
Mazzarella, E. [2 ]
Grisotto, S. [2 ]
Borroni, M. [2 ]
Fallai, C. [1 ]
Carrara, M. [2 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Diagnost Imaging & Radiotherapy, Radiotherapy 2, Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Dept Diagnost Imaging & Radiotherapy, Med Phys Unit, Milan, Italy
关键词
D O I
10.1016/S0167-8140(17)32147-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP-1785
引用
收藏
页码:S980 / S981
页数:2
相关论文
共 41 条
  • [31] The correlation between vaginal cuff doses and vaginal vault complications in patients with cancer of the uterine cervix, treated with high dose rate (HDR) brachytherapy (BT)
    Bernstein, Z.
    Amit, A.
    Nevelsky, A.
    Bar Deroma, R.
    Gez, E.
    Kuten, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S274 - S274
  • [32] Dose optimization practice pattern in single-channel vaginal cylinder HDR brachytherapy influences bladder and rectal doses
    Yaparpalvi, R.
    Shah, S.
    Sharma, R.
    Bloom, B.
    Hong, L.
    Mah, D.
    Engler, M.
    Kalnicki, S.
    Garg, M.
    Mutyala, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S698 - S698
  • [33] Commissioning a Commercial HDR Brachytherapy Multi-Channel Vaginal Cylinder for Clinical Use Without the Use of Radiographic Film
    Nichols, G.
    Price, M.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [34] Adjuvant Vaginal Cuff HDR Brachytherapy Prescribed to an Active Length of Two Centimeters Using Suspender Immobilization: A Baylor Scott & White Experience
    Jensen, Garrett
    El-Ghamry, Moataz
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (02): : E37 - E37
  • [35] Role of non-absorbable oral antibiotics in bowel preparation for intracavitary brachytherapy: effects of rifaximin on rectal dosimetric parameters during vaginal cuff brachytherapy
    Razmjoo, Sasan
    Bagheri, Ali
    Shahbazian, Hodjatollah
    Hosseini, Seyed-Mohammad
    Ebrahimian-Tabrizi, Faezeh
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (04) : 426 - 432
  • [36] Pre-Treatment Simulation Tolerance and Dosimetry Effects On OARs for the Cylinder High Dose Rate (HDR) Brachytherapy Treatment of Vaginal Cuff Cancer
    Shi, C.
    Fang, D.
    Iannuzzi, C.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [37] Excellent local control by HDR-brachytherapy of the vaginal vault with three fractions of 5-6.7Gy in 5mm depths in postoperative early stage endometrial carcinoma
    Astner, S.
    Heydemann-Obradovic, A.
    Thamm, R.
    Hoelzel, D.
    Kiechle, M.
    Hoess, C.
    Molls, M.
    Roeper, B.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S257 - S258
  • [38] Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?
    Yaowen Zhang
    Faegheh Noorian
    Rosa Abellana
    José Rochera
    Antonio Herreros
    Gabriela Antelo
    Valentina Lancellotta
    Luca Tagliaferri
    Qian Han
    Aureli Torne
    Angeles Rovirosa
    Clinical and Translational Oncology, 2023, 25 : 1748 - 1755
  • [39] Optimizing Toxicity and Local Control in Adjuvant Vaginal Cuff HDR brachytherapy: Stand vs. Suspender Immobilization and One vs. Two-centimeter Active Length Prescriptions
    Jensen, G. L.
    Barry, P. N., Jr.
    El-Ghamry, M. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E486 - E487
  • [40] Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2-late vaginal complications in 3D-vaginal-cuff brachytherapy (interventional radiotherapy)?
    Zhang, Yaowen
    Noorian, Faegheh
    Abellana, Rosa
    Rochera, Jose
    Herreros, Antonio
    Antelo, Gabriela
    Lancellotta, Valentina
    Tagliaferri, Luca
    Han, Qian
    Torne, Aureli
    Rovirosa, Angeles
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06) : 1748 - 1755